Latest News

• 
  COVID-19

  NMPA (China) approves Paxlovid conditionally to treat COVID-19 – Pfizer

  Written by Charlie King | 30 Jun 2022

  China’s medical products regulator has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the… read more.

• 
  Male & Female Health

  Calls for mental health of both parents to be considered during the perinatal period

  Written by Charlie King | 30 Jun 2022

  Perinatal mood disorders such as postnatal depression and perinatal anxiety, may affect both mothers and fathers simultaneously, finds a new systematic review and meta-analysis* led by UCL researchers…. read more.

• 
  Haematology

  EU approves Oxbryta for hemolytic anemia due to sickle cell disease – Global Blood Therapeutics

  Written by Charlie King | 29 Jun 2022

  Global Blood Therapeutics announced the European Commission (EC) has granted Marketing Authorization for Oxbryta (voxelotor) for the treatment of hemolytic anemia due to sickle cell disease (SCD) in… read more.

• 
  Care of the Elderly

  Sight problems may increase dementia risk in older adults

  Written by Charlie King | 29 Jun 2022

  Older adults with untreated sight conditions may be at increased risk of dementia, according to a new systematic review and meta-analysis of 16 studies involving 76,373 participants. The… read more.

• 
  Pain

  Approval of Zynrelef by Health Canada for the management of postoperative pain – Heron Therapeutics

  Written by Charlie King | 28 Jun 2022

  Heron Therapeutics, Inc., announced that Health Canada has issued a Notice of Compliance (NOC) to commercialize Zynrelef (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound… read more.

• 
  Haematology

  App to help doctors help patients with leukemia

  Written by Charlie King | 28 Jun 2022

  lymphocytic leukaemia (CLL) will develop a serious infection or need early treatment for CLL. 10 percent of these risk dying within a month. In order to help these… read more.

• 
  Dermatology

  Scarless skin grafting using mussel adhesive protein

  Written by Charlie King | 27 Jun 2022

  One of the biggest concerns for patients undergoing skin grafting is scarring post-surgery and the regeneration of transplanted skin. The depth of scarring after suturing varies depending on… read more.

• 
  Diabetes & Endocrinology

  Endocrine Society urges Congress to pass bill to make insulin more affordable for people with diabetes

  Written by Charlie King | 27 Jun 2022

  The Endocrine Society announces its endorsement of the bipartisan insulin bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) that would take steps to reduce out-of-pocket… read more.

• 
  Oncology & Haematology

  New approach to prostate cancer improves 5-year survival

  Written by Bruce Sylvester | 26 Jun 2022

  A combination of hormone therapy and pelvic lymph node radiation improves survival of prostate cancer patients, researchers reported on May 26, 2022 in The Lancet. “We can now… read more.

• 
  Haematology

  New research to help address blood shortages in Ireland

  Written by Charlie King | 26 Jun 2022

  A study by RCSI University of Medicine and Health Sciences has identified barriers and motivators to blood donation for people from ethnic minority groups in Ireland. The findings… read more.

• 
  Oncology & Haematology

  Improved treatment emerges for mantle cell lymphoma

  Written by Bruce Sylvester | 25 Jun 2022

  Addition of ibrutinib to standard chemotherapy for patients over 65 with previously untreated mantle cell lymphoma (MCL) has led to significantly improved progression-free survival, researchers reported on June… read more.

• 
  Mental Health

  Increased overdose and mental health risks persist two years after opioid dose reduction

  Written by Charlie King | 25 Jun 2022

  Does dose reduction for patients on stable opioid therapy have long-term overdose and mental health risks? Researchers from the UC Davis Center for Healthcare Policy and Research examined… read more.